Literature DB >> 7112494

Pharmacological studies on the antithrombotic action of hirudin in experimental animals.

F Markwardt, J Hauptmann, G Nowak, C Klessen, P Walsmann.   

Abstract

The pharmacodynamics and pharmacokinetics of hirudin were studied in dogs, rabbits and rats. Hirudin proved to be a well tolerated substance with low toxicity. After intravenous injection it was eliminated with a half time of 50 to 60 min. It was nearly completely excreted through the kidneys in biologically active form. The efficacy of hirudin in preventing venous thrombosis, vascular shunt occlusion and disseminated intravascular coagulation in rats was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7112494

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

Review 1.  Hirudin, a new therapeutic tool?

Authors:  J Bichler; H Fritz
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

2.  Catabolism of hirudin and thrombin-hirudin complexes in the rat.

Authors:  J Bichler; J W Baynes; S R Thorpe
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

3.  Pharmacokinetics of rec-hirudin in healthy volunteers after intravenous administration.

Authors:  J M Cardot; G Y Lefèvre; J A Godbillon
Journal:  J Pharmacokinet Biopharm       Date:  1994-04

4.  Hirudin: Its Biology and Clinical Use.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

5.  Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis.

Authors:  R P Harvey; E Degryse; L Stefani; F Schamber; J P Cazenave; M Courtney; P Tolstoshev; J P Lecocq
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

6.  Optimization of the expression system using galactose-inducible promoter for the production of anticoagulant hirudin in Saccharomyces cerevisiae.

Authors:  E S Choi; J H Sohn; S K Rhee
Journal:  Appl Microbiol Biotechnol       Date:  1994-12       Impact factor: 4.813

7.  Local hirudin application--an aid in preventing occlusion of an arteriovenous fistula in dialysis patients?

Authors:  E Minar; J Zazgornik
Journal:  Klin Wochenschr       Date:  1985-02-15

8.  The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit.

Authors:  G R May; W Paul; P Crook; K D Butler; C P Page
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

9.  The conformations of hirudin in solution: a study using nuclear magnetic resonance, distance geometry and restrained molecular dynamics.

Authors:  G M Clore; D K Sukumaran; M Nilges; J Zarbock; A M Gronenborn
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

10.  Effects of Natural Hirudin and Low Molecular Weight Heparin in Preventing Deep Venous Thrombosis in Aged Patients with Intertrochanteric Fracture.

Authors:  Zhengdong Zhang; Zheng Li; Jun Li; Lei Liu
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.